A Bayesian analysis of doubly censored data using a hierarchical Cox model.
Two common statistical problems in pooling survival data from several studies are addressed. The first problem is that the data are doubly censored in that the origin is interval censored and the endpoint event may be right censored. Two approaches to incorporate the uncertainty of interval-censored origins are developed, and then compared with more usual analyses using imputation of a single fixed value for each origin. The second problem is that the data are collected from multiple studies and it is likely that heterogeneity exists among the study populations. A random-effects hierarchical Cox proportional hazards model is therefore used. The scientific problem motivating this work is a pooled survival analysis of data sets from three studies to examine the effect of GB virus type C (GBV-C) coinfection on survival of HIV-infected individuals. The time of HIV infection is the origin and for each subject this time is unknown, but is known to lie later than the last time at which the subject was known to be HIV negative, and earlier than the first time the subject was known to be HIV positive. The use of an approximate Bayesian approach using the partial likelihood as the likelihood is recommended because it more appropriately incorporates the uncertainty of interval-censored HIV infection times.
Zhang
Wei
W
Department of Biostatistics, University of Iowa, Iowa City, IA, USA. wzhang@rdg.boehringer-ingelheim.com
Chaloner
Kathryn
K
Cowles
Mary Kathryn
MK
Zhang
Ying
Y
Stapleton
Jack T
JT
D001499:Bayes Theorem; D015331:Cohort Studies; D003627:Data Interpretation, Statistical; D029407:GB virus C; D015658:HIV Infections; D006801:Humans; D016016:Proportional Hazards Models; D016019:Survival Analysis
Science. 1988 Jun 3;240(4857):1333-5
3163848
Ann Intern Med. 1985 Aug;103(2):210-4
2990275
Hepatology. 1998 Aug;28(2):379-84
9696000
Lancet. 2004 Jun 19;363(9426):2040-6
15207954
J Infect Dis. 2005 Dec 15;192(12):2147-51
16288381
Z Gastroenterol. 1998 Jan;36(1):41-53
9531689
Biostatistics. 2005 Jan;6(1):145-55
15618533
AIDS. 2005 Nov 4;19(16):1910-2
16227800
J Infect Dis. 1999 Apr;179(4):783-9
10068572
N Engl J Med. 2001 Sep 6;345(10):707-14
11547739
J Clin Microbiol. 2006 Sep;44(9):3105-13
16954234
N Engl J Med. 1996 Jun 6;334(23):1536-7
8618611
N Engl J Med. 2001 Sep 6;345(10):715-24
11547740
HIV Med. 2006 Apr;7(3):173-80
16494631
Semin Liver Dis. 2003 May;23(2):137-48
12800067
Lifetime Data Anal. 1998;4(1):5-28
9567053
Pediatrics. 2006 Jan;117(1):184-91
16396876
Stat Med. 1995 Oct 30;14(20):2173-90
8552895
AIDS. 2004 Apr 9;18(6):877-86
15060435
Stat Med. 2008 Feb 20;27(4):529-42
17694594
AIDS. 2005 Aug 12;19(12):1267-72
16052081
Biometrics. 1997 Mar;53(1):230-42
9147593
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):209-13
9495219
J Infect Dis. 2006 Feb 1;193(3):451-4
16388494
J Infect Dis. 2005 Jun 15;191(12):2157-8; author reply 2158-60
15898008
J Infect Dis. 2005 Mar 1;191(5):678-85
15688280
Am J Epidemiol. 1992 Feb 15;135(4):428-37
1550094
N Engl J Med. 2004 Mar 4;350(10):981-90
14999110
AIDS. 2002 Dec 6;16(18):2482-5
12461426
AIDS. 2003 Jul 4;17(10):1457-62
12824783
Stat Med. 1992 Sep 15;11(12):1569-78
1439361
Biometrics. 1998 Dec;54(4):1486-97
9883547
Stat Med. 1995 Dec 15;14(23):2523-35
8746886